Description:BMS-6690514, with the CAS number 859853-30-8, is a chemical compound that has been investigated primarily for its potential therapeutic applications, particularly in the field of oncology. It is classified as a small molecule inhibitor, specifically targeting certain pathways involved in cancer cell proliferation and survival. The compound is known to interact with specific proteins or enzymes that play a crucial role in tumor growth, making it a candidate for cancer treatment. BMS-6690514 exhibits properties typical of many targeted therapies, including selectivity for cancer cells over normal cells, which may lead to reduced side effects compared to traditional chemotherapy. Its pharmacokinetic profile, including absorption, distribution, metabolism, and excretion, is essential for determining its efficacy and safety in clinical settings. As research continues, the compound's full potential and mechanism of action are being elucidated, contributing to the broader understanding of targeted cancer therapies.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![(3R,4R)-4-AMINO-1-[[4-[(3-METHOXYPHENYL)AMINO]PYRROLO[2,1-F][1,2,4]TRIAZIN-5-YL]METHYL]PIPERIDIN-3…](https://static.cymitquimica.com/products/10/thumb/F502781.jpg)
